Quantamental Technologies’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,106
Closed -$310K 619
2022
Q3
$310K Buy
+5,106
New +$161K 0.12% 297
2019
Q4
Sell
-3,999
Closed -$31K 1116
2019
Q3
$31K Sell
3,999
-14
-0.3% -$124 0.01% 1101
2019
Q2
$42K Sell
4,013
-116
-3% -$1.19K 0.02% 946
2019
Q1
$50K Buy
4,129
+2,429
+143% +$30.3K 0.02% 867
2018
Q4
$18K Buy
+1,700
New +$20.2K 0.01% 1036

Other funds holding PRTA

Quantamental Technologies's PRTA Position: Q4 2022 in Review

Quantamental Technologies sold out of Prothena Corp (PRTA) in Q4 2022, closing a stake of 5,106 shares — an estimated $310K sold.

Quantamental Technologies first reported a position in PRTA in Q4 2018 and held it in 5 quarters. The position peaked at $310K in Q3 2022. 201 funds tracked by Wall St. Rank hold PRTA as of Q4 2022.

  • Quantamental Technologies reported no remaining Prothena Corp position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 5,106 Prothena Corp shares in Q4 2022, an estimated $310K.
  • Quantamental Technologies first reported a position in Prothena Corp in Q4 2018 and held it in 5 quarters.
  • Quantamental Technologies's Prothena Corp position peaked at $310K in Q3 2022.
  • 201 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.